Literature DB >> 22047077

Targeting the assembly of bacterial cell division protein FtsZ with small molecules.

Claudia Schaffner-Barbero1, Mar Martín-Fontecha, Pablo Chacón, José M Andreu.   

Abstract

FtsZ is the key protein of bacterial cell division and an emergent target for new antibiotics. It is a filament-forming GTPase and a structural homologue of eukaryotic tubulin. A number of FtsZ-interacting compounds have been reported, some of which have powerful antibacterial activity. Here we review recent advances and new approaches in modulating FtsZ assembly with small molecules. This includes analyzing their chemical features, binding sites, mechanisms of action, the methods employed, and computational insights, aimed at a better understanding of their molecular recognition by FtsZ and at rational antibiotic design.

Mesh:

Substances:

Year:  2011        PMID: 22047077     DOI: 10.1021/cb2003626

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  35 in total

1.  Computer aided design of FtsZ targeting oligopeptides.

Authors:  Stefano Rendine; Chacko Jobichen; Stefano Pieraccini; Prerna Domadia; J Sivaraman; Pierangelo Francescato; Giovanna Speranza; Maurizio Sironi
Journal:  RSC Adv       Date:  2012-12-21       Impact factor: 3.361

2.  Understanding nucleotide-regulated FtsZ filament dynamics and the monomer assembly switch with large-scale atomistic simulations.

Authors:  Erney Ramírez-Aportela; José Ramón López-Blanco; José Manuel Andreu; Pablo Chacón
Journal:  Biophys J       Date:  2014-11-04       Impact factor: 4.033

3.  TXA709, an FtsZ-Targeting Benzamide Prodrug with Improved Pharmacokinetics and Enhanced In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus.

Authors:  Malvika Kaul; Lilly Mark; Yongzheng Zhang; Ajit K Parhi; Yi Lisa Lyu; Joan Pawlak; Stephanie Saravolatz; Louis D Saravolatz; Melvin P Weinstein; Edmond J LaVoie; Daniel S Pilch
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

4.  Enterococcal and streptococcal resistance to PC190723 and related compounds: molecular insights from a FtsZ mutational analysis.

Authors:  Malvika Kaul; Yongzheng Zhang; Ajit K Parhi; Edmond J Lavoie; Steve Tuske; Eddy Arnold; John E Kerrigan; Daniel S Pilch
Journal:  Biochimie       Date:  2013-06-25       Impact factor: 4.079

5.  Complete genome sequence of Riemerella anatipestifer reference strain.

Authors:  Xiaojia Wang; DeKang Zhu; MingShu Wang; AnChun Cheng; RenYong Jia; Yi Zhou; Zhengli Chen; QiHui Luo; Fei Liu; Yin Wang; Xiao Yue Chen
Journal:  J Bacteriol       Date:  2012-06       Impact factor: 3.490

6.  An FtsZ-targeting prodrug with oral antistaphylococcal efficacy in vivo.

Authors:  Malvika Kaul; Lilly Mark; Yongzheng Zhang; Ajit K Parhi; Edmond J Lavoie; Daniel S Pilch
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

7.  Synthesis of 9-Dechlorochrysophaentin A Enables Studies Revealing Bacterial Cell Wall Biosynthesis Inhibition Phenotype in B. subtilis.

Authors:  Christopher R Fullenkamp; Yen-Pang Hsu; Ellen M Quardokus; Gengxiang Zhao; Carole A Bewley; Michael VanNieuwenhze; Gary A Sulikowski
Journal:  J Am Chem Soc       Date:  2020-09-08       Impact factor: 15.419

8.  Substituted 1,6-diphenylnaphthalenes as FtsZ-targeting antibacterial agents.

Authors:  Yongzheng Zhang; Daniel Giurleo; Ajit Parhi; Malvika Kaul; Daniel S Pilch; Edmond J LaVoie
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

9.  In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model.

Authors:  Alexander J Lepak; Ajit Parhi; Michaela Madison; Karen Marchillo; Jamie VanHecker; David R Andes
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

10.  Antimicrobial activity of various 4- and 5-substituted 1-phenylnaphthalenes.

Authors:  Cody Kelley; Songfeng Lu; Ajit Parhi; Malvika Kaul; Daniel S Pilch; Edmond J Lavoie
Journal:  Eur J Med Chem       Date:  2012-12-20       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.